2020 saw a female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 of 22.9% in Togo, a decrease of 0.1% (-0.4%).
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Togo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Togo
Out-of-pocket expenditure PPP per capita
intl dollar94
+intl dollar7
(2022)
Newborns protected against tetanus
83%
0%
(2023)
Female wasting in children
5.3%
-0.3%
(2017)
Birth registration
82.9%
+4.9%
(2017)
Female prevalence of HIV
0.8%
0%
(2022)
Contraceptive modern method prevalence
21.4%
+4.1%
(2017)
Togo Female CVD, cancer, diabetes or CRD between 2000 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 22.9% | -0.1% |
| 2020 | 23% | +0.1% |
| 2019 | 22.9% | -0.3% |
| 2018 | 23.2% | -0.3% |
| 2017 | 23.5% | -0.3% |
| 2016 | 23.8% | -0.1% |
| 2015 | 23.9% | +0.1% |
| 2014 | 23.8% | -0.2% |
| 2013 | 24% | -0.1% |
| 2012 | 24.1% | -0.1% |
| 2011 | 24.2% | -0.1% |
| 2010 | 24.3% | -0.2% |
| 2009 | 24.5% | 0% |
| 2008 | 24.5% | +0.1% |
| 2007 | 24.4% | -0.1% |
| 2006 | 24.5% | -0.1% |
| 2005 | 24.6% | 0% |
| 2004 | 24.6% | -0.4% |
| 2003 | 25% | -0.2% |
| 2002 | 25.2% | -0.1% |
| 2001 | 25.3% | +0.1% |
| 2000 | 25.2% |